Search

Chuanhai Cao

from Tampa, FL
Age ~60
Get Report
Also known as:
Chuanhai Coa, Chuan Hai Cao, Chuanhui H Cao, Hai Cao Chuanhui, A Ministry
Phone and address:
813 Druid Hills Rd, Tampa, FL 33617
Related to:
Bai Yun, 56Bai Yun, 48
Connected to:
Aileen T Cao, 44Alyssa M Cao, 35Bai Cao, 109Bao J Cao, 58Bay T Cao, 78Billy P Cao, 40Bohao Cao, 38Bojian Cao, 42Cai V Cao, 104Canh Cao, 34

Chuanhai Cao Phones & Addresses

  • 813 Druid Hills Rd, Tampa, FL 33617
  • 2727 Fletcher Ave, Tampa, FL 33618 (813) 968-1827
  • 3600 Fletcher Ave, Tampa, FL 33613
  • Temple Terrace, FL
  • Land O Lakes, FL
  • Oviedo, FL
  • Lovettsville, VA

Resumes

Resumes

Chuanhai Cao Photo 1

Assistant Professor At Florida Covering Kids And Families

View page
Location:
Tampa, FL
Industry:
Individual & Family Services
Work:
Florida Covering Kids and Families
Assistant Professor at Florida Covering Kids and Families
Skills:
Pharmacology
Neuroscience
Molecular Biology
Immunohistochemistry
Cell Biology
Alzheimer's Disease
Clinical Research
Science
Research
Teaching
Languages:
Mandarin
Chuanhai Cao Photo 2

Associate Professor

View page
Location:
Tampa, FL
Work:

Associate Professor
Chuanhai Cao Photo 3

Research Assistant Professor

View page
Location:
Tampa, FL
Industry:
Research
Work:
University of South Florida
Research Assistant Professor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Chuanhai Cao
Vice President, Principal
Panoab Inc
Business Services at Non-Commercial Site
813 Druid Hl Rd, Tampa, FL 33617
3802 Spectrum Blvd, Tampa, FL 33612
Chuanhai Cao
Director
Chinese Associate Reformed Presbyterian Church Inc
PO Box 14508, Clearwater, FL 33766
28125 County Line Rd, Zephyrhills, FL 33543
Chuanhai Cao
President, Vice President
Tampa Chinese Presbyterian Church Inc
14925 N Blvd, Tampa, FL 33613

Publications

Us Patents

Amyloid Beta Peptides And Methods Of Use

View page
US Patent:
8188046, May 29, 2012
Filed:
Oct 12, 2007
Appl. No.:
12/444647
Inventors:
Chuanhai Cao - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
A61K 38/17
A61P 25/28
C07H 21/00
C07K 14/435
US Classification:
514 178, 514 213, 536 235, 530324
Abstract:
The application describes several mutant amyloid beta peptides and specific regions which are useful in the therapeutic and diagnostic of neurological diseases. The application further describes methods of using these mutant peptides as treatment and reagents for diagnosis of diseases. The application further describes diagnostic kits and pharmaceutical compositions for use in therapy to treat neurological diseases including but not limited to Alzheimer's disease and various forms of mild cognitive impairments.

Method Of Diagnosing Or Assessing Risk For Parkinson's Disease Or Alzheimer's Disease Using Tcr Clonality

View page
US Patent:
8383347, Feb 26, 2013
Filed:
May 3, 2010
Appl. No.:
12/772728
Inventors:
Chuanhai Cao - Temple Terrace FL, US
Xiaoyang Lin - Tampa FL, US
Huntington Potter - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435 612, 435 912
Abstract:
Changes in adaptive immune system were identified and correlated as a predictor of Aβand Aβand AD progression. T-cell, B-cell, TCR and BCR profiles were used to correlate clinical progression of AD. The CDR3 region was spectratyped, showing the clonality of the CDR3 region. This intrafamily gene fragment length profile was compared to age-matched controls, thereby indicating the existence of a neurodegenerative disease. The novel method is useful in diagnosing neurodegenerative disease, like Parkinson's disease, HIV-associated Dementia, or Alzheimer's disease. Moreover, this permits the clinical identification of patients at a very early stage of AD and/or monitoring the potential benefits of disease modifying therapeutics.

A Method For The Separation Anti-Amyloid Beta Antibody With Amyloid Beta Peptide

View page
US Patent:
20070015218, Jan 18, 2007
Filed:
Apr 14, 2006
Appl. No.:
11/279828
Inventors:
Chuanhai Cao - Tampa FL, US
Qingyou Li - Tampa FL, US
David Morgan - Clearwater FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
G01N 33/567
G01N 33/53
US Classification:
435007200
Abstract:
The present invention is a method of effectively dissociating an antibody and antigen from the complex they form. The method enables researchers to accurately identify anti-amyloid beta peptide and its antibody from sera samples. It can also be used for the evaluation of the outcome of Alzheimer's patient treatment based on the amyloid peptide load and antibody level in the sera.

Immunotherapy For Treatment Of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides

View page
US Patent:
20100136063, Jun 3, 2010
Filed:
Nov 16, 2009
Appl. No.:
12/619476
Inventors:
CHUANHAI CAO - TAMPA FL, US
XIAOYANG LIN - TAMPA FL, US
KURT BREITENKAMP - SAN DIEGO CA, US
HABIB SKAFF - TAMPA FL, US
KEVIN N. SILL - TAMPA FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - TAMPA FL
INTEZYNE TECHNOLOGIES, INC. - TAMPA FL
International Classification:
A61K 38/16
A61K 9/00
A61P 43/00
US Classification:
424400, 514 12
Abstract:
The present invention relates to the field of polymer chemistry and more particularly to encapsulated peptides and uses thereof.

Prevention And Treatment Of Alzheimer's Disease Through Electromagnetic Field Exposure

View page
US Patent:
20120065456, Mar 15, 2012
Filed:
Sep 12, 2011
Appl. No.:
13/230415
Inventors:
Gary W. Arendash - Prescott AZ, US
Chuanhai Cao - Temple Terrace FL, US
Jun Tan - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61N 2/02
US Classification:
600 13
Abstract:
The invention includes a method of treating and preventing a neurological disorder, such as Alzheimer's Disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period. Preferably, each individual treatment (comprising exposure to the predetermined frequency for the predetermined absorption period) is continued at a predetermined schedule (preferably daily) for a predetermined treatment period.The predetermined frequency, according to a preferred embodiment, is about 918 MHz with a specific absorption rate (SAR) of about 0.25 W/kg+/−2 dB. The predetermined absorption period of this preferred embodiment is about one hour. The treatment period is long-term, being greater than about 6 months and preferably between about 7 and 9 months.

Anti-Hiv Activity Of The Opioid Antagonist Naloxone

View page
US Patent:
8067430, Nov 29, 2011
Filed:
Jul 29, 2004
Appl. No.:
10/902471
Inventors:
Kenneth E. Ugen - Tampa FL, US
Steven Specter - Tampa FL, US
Susan B. Nyland - Hershey PA, US
Chuanhai Cao - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
A61K 31/485
US Classification:
514282
Abstract:
A method of treating HIV infection by using the novel anti-HIV activity of the opioid antagonist naloxone.

Compositions And Methods For Treating Alzheimers Disease

View page
US Patent:
20220280613, Sep 8, 2022
Filed:
Jul 10, 2020
Appl. No.:
17/626205
Inventors:
- TAMPA FL, US
Chuanhai Cao - Tampa FL, US
International Classification:
A61K 38/28
A61K 31/352
A61K 31/4045
A61P 25/28
A61K 9/107
A61K 47/24
A61K 47/10
A61K 47/14
Abstract:
The present application relates to compositions comprising (i) THC; (ii) melatonin; and (iii) insulin and methods of using same to Alzheimer's disease in a subject in need thereof without the psychological impairment and side effects associated with THC.

Extreme Low Dose Thc As A Therapeutic And Prophylactic Agent For Alzheimer's Disease

View page
US Patent:
20220265598, Aug 25, 2022
Filed:
Jan 9, 2020
Appl. No.:
16/738351
Inventors:
- Tampa FL, US
Chuanhai Cao - Tampa FL, US
International Classification:
A61K 31/352
A61P 25/28
Abstract:
Alzheimer's disease is treated using THC (alone, or in combination with melatonin) administered in an ultra-low dose amount sufficient to (i) reduce Aβ protein levels; (ii) reduce Aβ aggregation: (iii) maintain AβPP protein levels; (iv) enhance mitochondrial functioning; (v) decrease phosphorylation of GSK-3β protein; (vi) decrease GSK-3β protein levels; (vii) decrease phosphorylation of Tau protein; and/or (viii) maintain Tau protein levels, in said patient without severe psychological impairments and side effects associated with higher doses of THC.
Control profile
Chuanhai Cao from Tampa, FL, age ~60 Get Report